Lung Diseases, Interstitial
Conditions
Brief summary
The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.
Interventions
assessment of interstitial lung disease using chest CT
Sponsors
Study design
Eligibility
Inclusion criteria
* Age: ≥ 18 years * patients with a known systemic disease bearing a risk for ILD * signed informed consent (for prospective part)
Exclusion criteria
* Age \< 18 years * comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis | 5 years | The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| FVC%pred (Forced vital capacity) at time of ILD diagnosis | 5 years | The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis |
Countries
Austria